- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00985686
E-Mental Health Adolescent Depression Program (LEAP) (LEAP)
Evaluation of a Spirituality Informed E-mental Health Intervention (LEAP Project) for Major Depressive Disorder in Adolescents and Young Adults - A Randomized Controlled Pilot Trial
The purpose of this project is to explore the potential value and practicality of an innovative depression intervention for young people. More specifically, the objectives of this project are:
to pilot the Internet-based Spirituality Program with depressed young people (age 13-24) in Calgary by:
- obtaining preliminary estimates on the impact of the program on the primary outcome of depression severity, and secondary outcomes of spiritual well-being and self-concept.
- obtaining preliminary estimates on response rates and remission rates to guide sample size estimations for a full size randomized trial.
- evaluating if the suggested research methodology is feasible with respect to recruitment rate, patient burden and clinical implementation to guide design of a full size randomized trial.
- to gather feedback from depressed young people, their families and referral sources in the community (schools, family physicians, mental health outpatient services) on the perceived value of the program and on ways to eventually make it available as a community resource for others dealing with depression.
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2M 3T1
- Canadian Institute of Natural and Integrative Medicine (CINIM)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 13-24 years of age
- meet DSM-IV-TR criteria for major depressive disorder (mild-moderate severity) based on the Children's Depression Rating Scale-Revised or the Hamilton Depression Rating Scale
- ability to comply with study intervention, provision of informed assent and/or parental consent
Exclusion Criteria:
In order to avoid confounding through a change in the use of mood altering substances or therapies and through underlying medical conditions, patients will be excluded for any of the following reasons:
- change in use of pharma-therapeutic or herbal treatment for depression in the last three month OR during the first 2 months of trial participation (mild to moderately depressed patients who have not had a change in their treatment in the last three months will be eligible to participate if it is foreseeable that their current treatment will continue unchanged for the first 2 months of trial participation)
- patients currently undergoing a specific psycho-therapeutic treatment that has been shown to be effective for depression (such as Cognitive Behavioral Therapy (CBT) or Interpersonal Therapy (IPT)) or planning to start such therapy in the next two months
- change in the use of medications that have mood altering effects in the last 3 months OR during the first 2 months of trial participation
- history of bipolar disorder, psychotic disorder or psychotic episodes, personality disorder, multiple suicide attempts; history of ADD/ADHD permitted if stabilized (no longer meets DSM-IV-TR criteria for active ADD/ADHD) for at least 2 months; stabilized treated ADD/ADHD permitted if on regular long acting medication and agree to continue
- uncontrolled medical conditions in the last 3 months (assessed by qualified physician)
- high suicide risk
- DSM-IV-TR diagnosis of substance dependence (except nicotine, caffeine) within past 12-months
- history of tx resistance to ≥ 2 antidepressant medications when treated for an adequate period with a therapeutic dose
- recent deaths in the family
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study Arm
Arm where participants began the LEAP Project intervention upon recruitment for an 8 week period.
|
In collaboration with experts from Alberta Health Services, the University of Calgary, and Mount Royal University, the Canadian Institute of Natural and Integrative Medicine (CINIM) has created the LEAP Project, a spirituality informed e-mental health intervention, for young people with major depressive disorders (see Appendix for sample materials).
It is an online, eight module, multimedia intervention delivered over eight weeks, requiring a weekly commitment of 2-3 hours.
The intervention is non-denominational and avoids a focus on any religious traditions.
The program aims to treat depression by guiding depressed young people through an exploration of spiritual concepts and principles.
|
Active Comparator: Waitlist Arm
Arm where participants received the LEAP Project intervention after an 8 week wait period. At 8 weeks, the results from the wait-list arm (no intervention) were compared to the results of the study arm (intervention completed). |
In collaboration with experts from Alberta Health Services, the University of Calgary, and Mount Royal University, the Canadian Institute of Natural and Integrative Medicine (CINIM) has created the LEAP Project, a spirituality informed e-mental health intervention, for young people with major depressive disorders (see Appendix for sample materials).
It is an online, eight module, multimedia intervention delivered over eight weeks, requiring a weekly commitment of 2-3 hours.
The intervention is non-denominational and avoids a focus on any religious traditions.
The program aims to treat depression by guiding depressed young people through an exploration of spiritual concepts and principles.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Children's Depression Rating Scale Revised (CDRS-R)
Time Frame: At 8 week intervals over a 24 week period
|
Measure of depression severity in individuals 13 to 18 years of age.
CDRS-R total raw scores includes the sum of 17 items, each item's scoring range is from 1 (no difficulties) to 5 (severe clinically significant difficulties) or 1 (no difficulties) to 7 (severe clinically significant difficulties), with a total possible raw score ranging from 17 to 113.
To meet eligibility requirements, participants required a total raw score of 40 to 70.
|
At 8 week intervals over a 24 week period
|
Hamilton Depression Rating Scale (HAMD)
Time Frame: At 8 week intervals over a 24 week period
|
Measure of depression severity in individuals 19 to 24 years of age.
HAMD total scores includes the sum of 17-items, with eight items scored on a range of 0 (absent) to 2 (marked or definite) and nine scored on a range of 0 (absent) to 4 (very severe).
The level of depression was based on the following scoring ranges: 7 or under not depressed, 8-13 some depressive symptoms but no depressive disorder, 12-15 mild depression, 16-19 moderate depression, 20-24 moderately severe depression, and 25+ severe depression.
To meet eligibility requirements, participants required a total score of 12-24.
|
At 8 week intervals over a 24 week period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Piers-Harris Children's Self-Concept Scale - Second Edition (Piers Harris 2)
Time Frame: At 8 week intervals over a 24 week period
|
Measure of self-concept in 13 to 18 year olds.
The scale can be completed in 10-15 minutes and includes 60 items covering six subscales: physical appearance and attributes, intellectual and school status, happiness and satisfaction, freedom from anxiety, behavioural adjustment and popularity.
|
At 8 week intervals over a 24 week period
|
Six Factor Self-Concept Scale
Time Frame: At 8 week intervals over a 24 week period
|
Measure of self concept in 19 to 24 year olds.
The Six-Factor Self-Concept Scale is a multidimensional measure of adult self-concept that was designed to have broad applicability across life settings, roles, and activities.
The scale consist of 115 items and assess six factors including likability, morality, task accomplishment, giftedness, power and vulnerability.
|
At 8 week intervals over a 24 week period
|
Profile of Mood States (POMS)
Time Frame: At 8 week intervals over a 24 week period
|
Measure of psychological well-being in 19 to 24 year olds.
The POMS has the format of an adjective check list and consists of 65 items.
It provides a total score of mood disturbance and six factor based subscale scores.
|
At 8 week intervals over a 24 week period
|
Spiritual Well-Being Scale (SWBS)
Time Frame: At 8 week intervals over a 24 week period
|
Measure of level spiritual well-being in 13-18 year olds.
The self administered 10-item version was used.
|
At 8 week intervals over a 24 week period
|
Spiritual Involvement and Belief Scale (SIBS)
Time Frame: At 8 week intervals over a 24 week period
|
Measure of spiritual well-being in 19 to 24 year olds.
The instrument is self-administered and contains 26 items in a Likert-type format.
|
At 8 week intervals over a 24 week period
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: John Toews, MD, FRCPC, Canadian Institute of Natural and Integrative Medicine
- Principal Investigator: Badri Rickhi, MB MD FRCPC, Canadian Institute of Natural and Integrative Medicine
- Principal Investigator: Jordan Cohen, MD, FRCPC, University of Calgary
- Principal Investigator: Dawne Clark, PhD, Mount Royal College
- Principal Investigator: John Griffith, BA MDiv, Spiritual Directions
- Principal Investigator: Hude Quan, PhD, University of Calgary
- Principal Investigator: Janet Chafe, MSW, RSW, Alberta Health Services
- Principal Investigator: Sabine Moritz, Bsc MSc, Alberta Health Services
- Principal Investigator: Patti Paccagnan, RN, BN, ACC, Canadian Institute of Natural and Integrative Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22549
- Ethics ID 22549 (Other Identifier: Conjoint Health Research Ethics Board)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Lawson Health Research InstituteTerminated
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Federal Research Center of Fundamental and Translational...CompletedDepression Moderate | Depression MildRussian Federation
Clinical Trials on LEAP Project
-
Clinique Romande de ReadaptationCompletedStroke | Multiple Sclerosis | Cerebral Palsy | Parkinson Disease | Spinal Cord Injuries | People With Impaired Lower Extremity FunctionSwitzerland
-
University of Massachusetts, WorcesterNational Institute of Nursing Research (NINR)CompletedHepatitis cUnited States
-
Istanbul UniversityNot yet recruitingScleroderma, Systemic | Rehabilitation | Physiotherapy | Rheumatology | Hand Rheumatism | Video Games
-
VA Office of Research and DevelopmentActive, not recruitingSuicidal Self-directed Violence | Suicidal Preparatory BehaviorUnited States
-
University of Puget SoundCompleted
-
Cardiff UniversityCompletedMultiple SclerosisUnited Kingdom
-
Universidad Rey Juan CarlosUnknownStroke | Brain Injuries, Traumatic | Treatment Adherence | Patient SatisfactionSpain
-
Seattle Children's HospitalNational Institutes of Health (NIH); National Center for Complementary and...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Fernanda CechettiRecruiting